News

Mounjaro, type 2 diabetes and Lilly

Mounjaro appears more heart protective than Trulicity in trial of Eli Lilly diabetes drugs
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling medication for the disease, in reducing the risk of heart attack and stroke in a large,
Lilly’s Mounjaro protects heart health in large diabetic study
The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, while showing greater weight loss and blood sugar control.
Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.
Eli Lilly says diabetes therapy Mounjaro leads to heart benefits in late-stage trial
Eli Lilly (LLY) stock in focus as its diabetes drug Mounjaro causes heart benefits suceeding in a late-stage trial versus its heart drug Trulicity. Read more here.
Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment
Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications in a large trial.
Lilly’s Mounjaro Cuts Risk of Heart Attacks, Strokes in Study
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro was about as good at preventing heart attacks and strokes as its older medicine Trulicity in a head-to-head study of the two treatments.
Eli Lilly's Mounjaro met goal of cardiovascular benefit in head-to-head trial with Trulicity
CNBC's Angelica Peebles joins 'Squawk Box' with the latest news from Eli Lilly. Two Democrats Withdraw from NGA Over Trump Mom Worried If New Rescue Dog Had ‘Bonded’ With Baby, Then She Caught Them Trump Just Crashed the Copper Market Forensics expert analysis of Jeffrey Epstein jail video contradicts government's claims Jamie Lee Curtis calls out Stephen Colbert for being 'in love with' her husband Christopher Guest: 'I'm fine with it' Suárez to Mariners,
Lilly shares slide as Mounjaro fails to outperform Trulicity in heart health study
Shares of Eli Lilly and Company (NYSE:LLY) dropped Thursday morning after the company announced that its diabetes treatment Mounjaro did not demonstrate superiority over Trulicity, its older GLP-1 medication,
Medscape9h

GLP-1 RAs May Up Optic Neuropathy Risk in Seniors With Diabetes

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...
Healio4h

Type 1 diabetes screening, identifying subtypes among key areas of scientific statement

Identifying type 1 diabetes before stage 1 and developing more tailored therapies through a better understanding of the ...
New Atlas1h

The three popular diets that clobber diabetes

After reviewing a series of studies involving hundreds of thousands of participants, a team of researchers found three eating ...

Our 19 Best Meal-Prep Recipes for Diabetes

These diabetes-friendly recipes, from lunch and dinner ideas to breakfast and snack inspiration, are all perfect for meal ...

AI model uses glucose spikes to reveal hidden diabetes risk before symptoms appear

To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test ...
ScienceAlert on MSN2h

Just One Diet Soda a Day May Raise Your Type 2 Diabetes Risk by 38%

Artificial sweeteners were introduced to offer a healthier alternative to sugar – but as a new study highlights, these ...
The Cardiology Advisor3h

Diabetes Progression Heightens Kidney Cancer Risk

Diabetes progression indicators, including chronic kidney disease and prolonged diabetes duration, were associated with greater kidney cancer risk.

Depression in diabetes: Chronic inflammation biomarkers can influence treatment success

People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim ...
Devdiscourse1h

EMS Unveils New Injector Pens for Diabetes and Obesity Treatment

Brazilian pharmaceutical company EMS announced the release of Olire and Lirux injector pens for obesity and type 2 diabetes, ...

Rylee Arnold Talks ‘DWTS’ & Type 1 Diabetes Battle (EXCLUSIVE)

Rylee Arnold, sister of professional dancer Lindsey Arnold, stole people's hearts when she first appeared on Dancing with the ...

I Was 'Diabetes Barbie' Long Before Mattel Made Her

A new Barbie with an insulin pump and CGM isn’t just a toy — she’s a symbol of visibility and a reminder to meet others with ...